Jocose 发表于 2025-3-23 13:47:04

Die aggregierte Güternachfrage: Yd=yd(P) reduced immunogenicity (Morrison et al., 1984, Morrison, 1985). In an attempt to further reduce immunogenicity, recombinant DNA technology has been used to generate “humanized” mAbs with mouse sequences largely confined to the hypervariable regions.

NIP 发表于 2025-3-23 14:38:40

Purification of Antibodies by Chromatographic Methods,esearch as well as for the diagnosis and treatment of a vast array of diseases. This is largely due to the fact that antibodies can be purposedly raised against many natural and synthetic molecules, which they later recognize in a highly specific way, even in very complex matrices.

figurine 发表于 2025-3-23 20:36:50

http://reply.papertrans.cn/16/1585/158461/158461_13.png

纠缠 发表于 2025-3-23 22:22:26

http://reply.papertrans.cn/16/1585/158461/158461_14.png

GEM 发表于 2025-3-24 04:35:49

Spezielle Typen von Minimierungsproblemen,lin, most of the initial wave of biotechnology products launched in the 1980s and 1990s were peptide hormones and enzymes licensed for indications with relatively small patient populations and for short-term rather than chronic use. Consequently, the market requirement for these products was frequently in the low kilogram range.

或者发神韵 发表于 2025-3-24 10:17:18

http://reply.papertrans.cn/16/1585/158461/158461_16.png

Compass 发表于 2025-3-24 12:53:58

http://reply.papertrans.cn/16/1585/158461/158461_17.png

抑制 发表于 2025-3-24 15:12:09

http://reply.papertrans.cn/16/1585/158461/158461_18.png

Emasculate 发表于 2025-3-24 20:25:13

http://reply.papertrans.cn/16/1585/158461/158461_19.png

Axillary 发表于 2025-3-25 02:36:12

Spezielle Typen von Minimierungsproblemen,lin, most of the initial wave of biotechnology products launched in the 1980s and 1990s were peptide hormones and enzymes licensed for indications with relatively small patient populations and for short-term rather than chronic use. Consequently, the market requirement for these products was frequen
页: 1 [2] 3 4 5
查看完整版本: Titlebook: Antibodies; Volume 1: Production G. Subramanian Book 2004 Springer Science+Business Media New York 2004 HIV.cancer.cancer therapy.developme